- Home
- PDYN vs DRUG Comparison
PDYN vs DRUG Comparison
Compare PDYN & DRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDYN
- DRUG
- Stock Information
- Founded
- PDYN 1983
- DRUG 2019
- Country
- PDYN United States
- DRUG United States
- Employees
- PDYN N/A
- DRUG N/A
- Industry
- PDYN Wholesale Distributors
- DRUG Pharmaceuticals and Biotechnology
- Sector
- PDYN Industrials
- DRUG Health Care
- Exchange
- PDYN Nasdaq
- DRUG Nasdaq
- Market Cap
- PDYN 225.7M
- DRUG 233.2M
- IPO Year
- PDYN N/A
- DRUG N/A
- Fundamental
- Price
- PDYN $7.87
- DRUG $25.95
- Analyst Decision
- PDYN
- DRUG Strong Buy
- Analyst Count
- PDYN 0
- DRUG 6
- Target Price
- PDYN N/A
- DRUG $83.25
- AVG Volume (30 Days)
- PDYN 1.9M
- DRUG 29.2K
- Earning Date
- PDYN 05-07-2025
- DRUG 05-15-2025
- Dividend Yield
- PDYN N/A
- DRUG N/A
- EPS Growth
- PDYN N/A
- DRUG N/A
- EPS
- PDYN N/A
- DRUG N/A
- Revenue
- PDYN $6,055,000.00
- DRUG N/A
- Revenue This Year
- PDYN N/A
- DRUG N/A
- Revenue Next Year
- PDYN $97.52
- DRUG N/A
- P/E Ratio
- PDYN N/A
- DRUG N/A
- Revenue Growth
- PDYN N/A
- DRUG N/A
- 52 Week Low
- PDYN $1.38
- DRUG $0.93
- 52 Week High
- PDYN $14.95
- DRUG $79.02
- Technical
- Relative Strength Index (RSI)
- PDYN 63.08
- DRUG 30.05
- Support Level
- PDYN $7.27
- DRUG $26.30
- Resistance Level
- PDYN $8.74
- DRUG $31.20
- Average True Range (ATR)
- PDYN 0.82
- DRUG 2.50
- MACD
- PDYN 0.13
- DRUG -0.55
- Stochastic Oscillator
- PDYN 70.71
- DRUG 5.59
About PDYN Palladyne AI Corp.
Palladyne AI Corp is a software company focused on autonomy for robotic systems and solutions. Its artificial intelligence and machine learning software seeks to revolutionize the capabilities of robots, enabling them to observe, learn, reason, and act in structured and unstructured environments. AI and ML software platform of the company empowers robots to perceive variations or changes in the real-world environment, enabling them to autonomously maneuver and manipulate objects accurately in response. Palladyne AI software has wide application, including in industries such as automotive, aviation, construction, defense, general manufacturing, infrastructure inspection, logistics and warehousing.
About DRUG Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.